Spotlight Therapeutics

Brief Description

Developer of next-generation gene editing therapeutics in a preclinical pipeline. The company creates programmable nucleases that selectively target and edit specific cell populations directly in the body. These engineered nucleases will enable direct intervention in vivo like a true administered biologic.


Tech Category

  • Medical Therapeutics

Join the IPIRA Mailing List




Accessibility | Nondiscrimination | Privacy